Despite Addiction Worries, FDA Panel Quietly Approves a Stronger Opioid

An FDA panel gave preliminary approval to a new kind of opioid drug meant to treat severe pain such as the kind people experience during surgery. The drug, sufentanil, which will be marketed under the brand name Dsuvia, is actually five to 10 times stronger than fentanyl. Surprisingly, the drug advisory committee voted 10-3, approving the drug. While this doesn’t set approval in stone, the FDA usually follows the advisory committee’s instruction. While the FDA has been pushing for more restrictions on opioids, there was no mention of fears of addiction or overdose in the discussions. There was one dissenting opinion, however; Raeford E. Brown Jr., MD, who chairs the committee. Dr. Brown doesn’t like the idea of allowing another potent and lethal opioid into the drug market, where fentanyl rules the day when it comes to accidental overdoses. He worries that some doctors won’t pay attention to dosing, which could also be dangerous. With the approval, the pharmaceutical company itself is pretty thrilled to reveal a new product.…

Continue Reading

FDA Says Kratom is Not Safe

FDA Says Kratom is Not Safe
A kratom leaf c/o YayImage.com

The FDA recently issued a warning that Kratom isn’t a safe way to withdraw from Oxycontin or other opioids -- or use for pain management. The plant that has been consumed for thousands of years by indigenous people, has made its way to America via the internet, marketed as a cure for opioid addiction, pain, and over a dozen other maladies that have normally been treated with pharmaceutical medication. One of the most storied uses of Kratom, however, is that it was once used as a “substitute” in East Asian countries during the opium epidemic. Users of the drug don’t believe that Kratom is not safe and tout the benefits of daily usage. Sure, some people use it heavily and experience withdrawal, they will admit, but this is no worse than caffeine withdrawal. Last year, the Drug Enforcement Administration tried to temporarily place the main psychoactive component found in Kratom into the schedule I category of the Controlled Substances Act, only to get a large amount of pushback from chronic…

Continue Reading